TROP2 Detection Kit
TROP2 Detection Kit
| Product | Detection Target Combinations | Approved Drugs (Cancer Types) | Clinical Trial Drugs (Cancer Types) |
|---|---|---|---|
| TROP2 Detection Kit | TROP2 | Sacituzumab Govitecan (Trodelvy)：Triple-negative breast cancer (TNBC), urothelial carcinoma (already marketed globally) | ESG401：PD-L1 Negative TNBC (Breakthrough Therapy) IBI130(Innovent Biologics): Solid Tumors (Phase I/II) SHR-A1921(Hengrui): Platinum-resistant ovarian cancer （DCR 100%） |
